Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune response
about
Vaccination for hepatitis C virus: closing in on an evasive targetImmunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzeesNeutralizing antibody response to hepatitis C virusA focus reduction neutralization assay for hepatitis C virus neutralizing antibodiesInduction of broad CD4+ and CD8+ T-cell responses and cross-neutralizing antibodies against hepatitis C virus by vaccination with Th1-adjuvanted polypeptides followed by defective alphaviral particles expressing envelope glycoproteins gpE1 and gpE2Evidence for Protection against Chronic Hepatitis C Virus Infection in Chimpanzees by Immunization with Replicating Recombinant Vaccinia VirusImmunotherapy for HCV infection: next steps.Elicitation of strong immune responses by a DNA vaccine expressing a secreted form of hepatitis C virus envelope protein E2 in murine and porcine animal modelsChallenge pools of hepatitis C virus genotypes 1-6 prototype strains: replication fitness and pathogenicity in chimpanzees and human liver-chimeric mouse models.Evaluation of IL-28B polymorphisms and serum IP-10 in hepatitis C infected chimpanzees.Will there be a vaccine to prevent HCV infection?Meta-analysis of hepatitis C virus vaccine efficacy in chimpanzees indicates an importance for structural proteins.Effect of route of delivery on heterologous protection against HCV induced by an adenovirus vector carrying HCV structural genes.Recent developments in target identification against hepatitis C virus.Immunoglobulin with High-Titer In Vitro Cross-Neutralizing Hepatitis C Virus Antibodies Passively Protects Chimpanzees from Homologous, but Not Heterologous, ChallengeInfectivity in chimpanzees (Pan troglodytes) of plasma collected before HCV RNA detectability by FDA-licensed assays: implications for transfusion safety and HCV infection outcomesDevelopment of prophylactic and therapeutic vaccines against hepatitis C virus.Prospects for a vaccine against the hepatitis C virus.Successful vaccination induces multifunctional memory T-cell precursors associated with early control of hepatitis C virusComparative Immunogenicity in Rabbits of the Polypeptides Encoded by the 5' Terminus of Hepatitis C Virus RNAGene therapy for viral hepatitis.High, broad, polyfunctional, and durable T cell immune responses induced in mice by a novel hepatitis C virus (HCV) vaccine candidate (MVA-HCV) based on modified vaccinia virus Ankara expressing the nearly full-length HCV genome.Adaptive immune responses to hepatitis C virus: from viral immunobiology to a vaccine.Prophylactic and Therapeutic Vaccination against Hepatitis C Virus (HCV): Developments and Future PerspectivesCurrent progress in development of hepatitis C virus vaccines.Immune mechanisms of vaccine induced protection against chronic hepatitis C virus infection in chimpanzees.Progress in the development of vaccines for hepatitis C virus infection.T- and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates.Mouse monoclonal antibody towards e1 specific epitope blocks viral entry and intracellular viral replication in vitro.Immunization With a Subunit Hepatitis C Virus Vaccine Elicits Pan-Genotypic Neutralizing Antibodies and Intrahepatic T-Cell Responses in Nonhuman Primates.The Role of FGL2 in the Pathogenesis and Treatment of Hepatitis C Virus Infection.Clearance of genotype 1b hepatitis C virus in chimpanzees in the presence of vaccine-induced E1-neutralizing antibodies.A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees.The Chimpanzee Model of Viral Hepatitis: Advances in Understanding the Immune Response and Treatment of Viral Hepatitis.Ratio of HCV structural antigens in protein-based vaccine formulations is critical for functional immune response induction.Treatment of chronic hepatitis C in non-responsive patients with pegylated interferon associated with ribavirin and thalidomide: report of six cases of total remission.
P2860
Q22305922-E386B5FE-0E9C-4213-B486-BB7D821CFAE8Q24685256-6913CB41-BAA3-49A4-841D-E5DA3C0A0A2AQ27027484-2F2DE7AB-5110-4EAD-8BEE-DB87034F58F5Q27478295-4CF72366-8836-4B75-ABDC-0934C32CABBEQ27486582-0FAEDB79-DE61-49AF-B71B-EA6E92F03890Q27487131-4EA3892B-7A16-437B-A2BC-9BC8D527D666Q30371832-D482F76F-D917-4A32-910B-2939169246C4Q33867634-3CDA4ACC-8D18-4ABA-8D05-CC4ED07D1B2EQ34140014-EA00E8EB-AB30-48D1-AFFE-DF443FE5C56FQ34464406-C095B8C0-D8D3-47BD-B7C6-62458F47E2BAQ34781537-853C676A-3293-481D-894F-163D6B11BF51Q34788785-EDA4B890-A22A-437A-8081-8C021AD85EC9Q35576891-E823BD93-8EDD-426D-97AE-449897847682Q35842500-74F0F07D-C251-4EFB-A51A-958A62B6F8D4Q35913863-20E30590-64D7-4375-9839-1E4637E639DDQ36058580-F66AF970-8304-4724-84E6-45A309B9A007Q36198667-F0B97490-5151-4D36-AF7A-8A723A72790AQ36233831-B1D8691A-F331-49B5-B30E-A06D07A2AD40Q36279345-61801091-0055-4F0D-98A1-7CA6B01707E4Q36280098-517FB7A9-8B09-40E5-B78E-606050D87BEBQ36708296-55F61CD1-3148-448B-8470-6F2CE23127B6Q36978998-E1866E20-09DE-4EF5-892C-C94F511600B2Q37309244-7D234A75-E68F-4BC5-9AB3-617D1670FAE5Q37945171-0F80F3A8-BD95-4F29-9882-86CD7B95D826Q38120201-EA738AF8-9856-447B-B7D7-86BE69DE74C9Q38334024-12AE24A9-1B4D-4750-8900-011F98866A83Q38635596-1BF2D164-3007-4D34-8C18-E874679D1234Q38758212-77F9700D-B0B6-48B0-BBC5-D0B2343ABBD2Q39092405-3FDA0F36-0634-4BC6-A691-2D8B3B47B428Q40248234-81C90F17-F28F-488B-8771-25CD037BF354Q41992660-D148DCB6-E27A-4FF9-AB5D-43C35FDF8F03Q42869198-D5B6E0D4-9923-4B8C-82BB-6F88991A30EDQ42998134-39741D46-3B03-4647-895E-DF4AFCD96F74Q47608448-EBCCF033-B044-4B7E-801F-61430A0E0167Q50551505-39FF6CB5-9EC8-4FD0-B8AB-AD5D11DB05F8Q50576318-5B4A79D6-0010-43F6-BC84-EAC8AC91849B
P2860
Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune response
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Control of heterologous hepati ...... heral T-helper immune response
@ast
Control of heterologous hepati ...... heral T-helper immune response
@en
Control of heterologous hepati ...... heral T-helper immune response
@nl
type
label
Control of heterologous hepati ...... heral T-helper immune response
@ast
Control of heterologous hepati ...... heral T-helper immune response
@en
Control of heterologous hepati ...... heral T-helper immune response
@nl
prefLabel
Control of heterologous hepati ...... heral T-helper immune response
@ast
Control of heterologous hepati ...... heral T-helper immune response
@en
Control of heterologous hepati ...... heral T-helper immune response
@nl
P2093
P2860
P1433
P1476
Control of heterologous hepati ...... heral T-helper immune response
@en
P2093
A Fournillier
B E Verstrepen
E J Verschoor
G Inchauspé
G Maertens
J A R Drexhage
P2860
P304
P356
10.1128/JVI.78.1.187-196.2004
P407
P577
2004-01-01T00:00:00Z